Concerns around the future management of more than €1.7 billion in funds connected to wards of court may be contributing to a ...

PTC Therapeutics withdrew its New Drug Application (NDA) resubmission for Translarna (ataluren) in nonsense mutation Duchenne muscular dystrophy (nmDMD) following feedback from FDA indicating that the ...

A growing body of global evidence suggests that rising military spending, while often justified by security concerns, can ...

The Indian Institute of Technology Bombay (IIT Bombay) on Friday said its researchers have found that too much mucus can weaken the lungs’ defences, which can make people more prone to allergy attacks ...

Civil Aviation Ministry initiates nationwide study to resolve urban height restrictions: Rammohan Naidu ...

The Indian Institute of Technology Bombay (IIT Bombay) on Friday said its researchers have found that too much mucus can weaken the lungs’ defences, which can make people more prone to allergy attacks ...

NDA ally TDP urges Centre to regulate social media for minors, citing digital addiction and safety risks in the 2026 national ...

The government is conducting a nationwide study to address height restrictions in urban areas while maintaining air safety, Union Civil Aviation Minister K Rammohan Naidu said on Friday.

Treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I under review.

KalVista Pharmaceuticals, Inc. is rated a Strong Buy due to EKTERLY's global launch and robust initial sales momentum. Read ...

Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read ...

Researchers at IIT Bombay reveal how excessive mucus creates gaps in our lungs’ defences, leaving us vulnerable to allergic ...